Gálvez V

Consorci Sanitari Parc Taulí , ,

2 papers

ArticleKetamine

What happens after stopping IN Esketamine? A prospective report of case series

Sagues T, Barnés A, Fernández C +3

Europe PMC2026
ArticleKetamine

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial: commentary, author response.

Loo C, Alonzo A, Barton D +9

Europe PMC2025